Eui‐Kyung Lee

1.9k total citations
123 papers, 1.4k citations indexed

About

Eui‐Kyung Lee is a scholar working on Economics and Econometrics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Eui‐Kyung Lee has authored 123 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Economics and Econometrics, 19 papers in Pulmonary and Respiratory Medicine and 16 papers in Oncology. Recurrent topics in Eui‐Kyung Lee's work include Health Systems, Economic Evaluations, Quality of Life (26 papers), Pharmaceutical Economics and Policy (13 papers) and Pharmaceutical Practices and Patient Outcomes (13 papers). Eui‐Kyung Lee is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (26 papers), Pharmaceutical Economics and Policy (13 papers) and Pharmaceutical Practices and Patient Outcomes (13 papers). Eui‐Kyung Lee collaborates with scholars based in South Korea, United States and United Kingdom. Eui‐Kyung Lee's co-authors include Hye‐Lin Kim, Hyun Jin Song, Ju‐Young Shin, Jin Hyun Nam, Jin‐Won Kwon, Sang‐Cheol Bae, Yoon‐Kyoung Sung, Young‐Suk Lim, Neeraj Kumar Mishra and In Su Kim and has published in prestigious journals such as PLoS ONE, Hepatology and Chemical Communications.

In The Last Decade

Eui‐Kyung Lee

115 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eui‐Kyung Lee South Korea 20 224 197 166 161 139 123 1.4k
Robert M. Perkins United States 20 512 2.3× 56 0.3× 53 0.3× 132 0.8× 271 1.9× 46 2.7k
Liisa Jaakkimainen Canada 20 429 1.9× 209 1.1× 207 1.2× 49 0.3× 248 1.8× 74 2.7k
Ji‐Young Choi South Korea 25 215 1.0× 111 0.6× 75 0.5× 20 0.1× 212 1.5× 157 2.0k
Vittorio Bertelè Italy 28 118 0.5× 620 3.1× 46 0.3× 51 0.3× 205 1.5× 85 2.2k
Diana Brixner United States 29 348 1.6× 497 2.5× 93 0.6× 20 0.1× 253 1.8× 174 2.7k
Fernando Valderrábano Spain 28 266 1.2× 430 2.2× 103 0.6× 24 0.1× 333 2.4× 87 3.2k
Gregorio T. Obrador Mexico 30 258 1.2× 408 2.1× 111 0.7× 40 0.2× 368 2.6× 69 3.3k
Luca Degli Esposti Italy 20 190 0.8× 295 1.5× 96 0.6× 9 0.1× 151 1.1× 200 1.7k
J. Michael Paterson Canada 19 241 1.1× 142 0.7× 145 0.9× 15 0.1× 160 1.2× 48 1.5k
Ted Wun United States 28 185 0.8× 317 1.6× 59 0.4× 31 0.2× 240 1.7× 75 2.9k

Countries citing papers authored by Eui‐Kyung Lee

Since Specialization
Citations

This map shows the geographic impact of Eui‐Kyung Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eui‐Kyung Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eui‐Kyung Lee more than expected).

Fields of papers citing papers by Eui‐Kyung Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eui‐Kyung Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eui‐Kyung Lee. The network helps show where Eui‐Kyung Lee may publish in the future.

Co-authorship network of co-authors of Eui‐Kyung Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Eui‐Kyung Lee. A scholar is included among the top collaborators of Eui‐Kyung Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eui‐Kyung Lee. Eui‐Kyung Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, Sehhoon, Jong‐Mu Sun, Se‐Hoon Lee, et al.. (2025). A matching-adjusted indirect comparison of first-line lorlatinib and alectinib for the treatment of ALK-rearranged advanced non-small cell lung cancer. European Journal of Cancer. 230. 115805–115805. 1 indexed citations
2.
Jang, Suk‐Chan, Gi‐Ae Kim, Young‐Suk Lim, Hye‐Lin Kim, & Eui‐Kyung Lee. (2025). Association between everolimus combination therapy and cancer risk after liver transplantation: A nationwide population-based quasi-cohort study. American Journal of Transplantation. 25(6). 1285–1295. 1 indexed citations
4.
Geue, Claudia, et al.. (2025). Comparative Effectiveness of Direct Oral Anticoagulants and Warfarin on Venous Thromboembolism in Cancer Patients. Cancer Medicine. 14(17). e71209–e71209. 1 indexed citations
5.
Kang, Sokbom, et al.. (2024). Cost-effectiveness of next-generation sequencing for advanced EGFR/ALK-negative non-small cell lung cancer. Lung Cancer. 197. 107970–107970. 1 indexed citations
6.
Lee, Myung Chul, et al.. (2024). Lipid-Based Nanoparticles Fused with Natural Killer Cell Plasma Membrane Proteins for Triple-Negative Breast Cancer Therapy. Pharmaceutics. 16(9). 1142–1142. 3 indexed citations
8.
Yang, So‐Young, et al.. (2022). Adherence is an optimal factor for maximizing the effective and safe use of oral anticoagulants in patients with atrial fibrillation. Scientific Reports. 12(1). 3413–3413. 6 indexed citations
10.
Lee, Eui‐Kyung, et al.. (2022). Value-Based Pricing and Budget Impact Analysis for Multi-Indication Drugs: A Case Study of Immunotherapies. International Journal of Environmental Research and Public Health. 19(7). 4105–4105. 3 indexed citations
11.
Yang, So‐Young, et al.. (2020). Does Early Retrograde Intrarenal Surgery Improve the Cost-Effectiveness of Renal Stone Management?. Yonsei Medical Journal. 61(6). 515–515. 9 indexed citations
12.
Kim, Hye‐Lin, et al.. (2020). Cost-effectiveness of antiviral treatment in adult patients with immune-tolerant phase chronic hepatitis B. Gut. 70(11). 2172–2182. 26 indexed citations
13.
Yang, So‐Young, et al.. (2020). Haematological cancer versus solid tumour end-of-life care: a longitudinal data analysis. BMJ Supportive & Palliative Care. 14(e1). e837–e844. 5 indexed citations
14.
Nam, Jin Hyun, et al.. (2019). A Comparison of Leukotriene Receptor Antagonists to Low-Dose Inhaled Corticosteroids in the Elderly with Mild Asthma. The Journal of Allergy and Clinical Immunology In Practice. 7(8). 2642–2652.e3. 8 indexed citations
15.
Song, Hyun Jin, Jin Hyun Nam, So‐Young Yang, et al.. (2018). Risk factors of asthma exacerbation based on asthma severity: a nationwide population-based observational study in South Korea. BMJ Open. 8(3). e020825–e020825. 49 indexed citations
16.
Kim, Hyelin, et al.. (2016). Analysis of Medical Use and Costs Related to the Management of Liver Cirrhosis Using National Patients Sample Data. Korean Journal of Clinical Pharmacy. 26(4). 341–347. 2 indexed citations
17.
Song, Hyun Jin, et al.. (2014). The addition of mifamurtide to chemotherapy improves lifetime effectiveness in children with osteosarcoma: a Markov model analysis. Tumor Biology. 35(9). 8771–8779. 7 indexed citations
18.
Sohn, Hyun Soon, et al.. (2014). Living arrangements, chronic diseases, and prescription drug expenditures among Korean elderly: vulnerability to potential medication underuse. BMC Public Health. 14(1). 1284–1284. 15 indexed citations
19.
Lee, Eui‐Kyung, et al.. (2008). Effect of $Al^{3+}$ Dopant on the Electrochemical Characteristics Of Spinel-type $Li_{4}Ti_{5}O_{12}$. Clean Technology. 14(3). 171–175. 1 indexed citations
20.
Lee, Eui‐Kyung, et al.. (2008). Electrochemical Characterization of Tin Oxide Prepared by Microwave Heating. Korean Journal of Chemical Engineering. 46(6). 1119–1123. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026